restor3d expands into the fields of robotics and navigation

restor3d, the leading medical device company for 3D-printed, personalized orthopedic implants, announced its strategic expansion into robotics and navigation with the appointment of experienced executives Larry Hazbun and Kirstin Widding.

The company, which specializes in producing implants that are perfectly matched to the anatomical features of individual patients, uses advanced 3D printing technologies to develop implants with optimal osseointegration. This customization allows for individualized treatment approaches designed to improve patient healing and recovery. With the new step towards robotics and navigation, restor3d plans to further optimize the surgical use of these implants through high-precision technologies.

“We welcome the addition of Larry Hazbun, Senior Vice President of Robotics and Kirstin Widding, Senior Vice President of Hip & Knee.” Said Ken Gall, restor3d Chief Commercial Officer and Co-Founder. “The addition of robotics and navigation technologies is a natural fit with personalization and a perfect compliment to our patient specific implants. By integrating these enabling technologies with our existing 3D-printed patient specific implants and instruments, restor3d is poised to offer a more holistic approach to personalized patient treatment.”

Larry Hazbun, who previously worked at Globus Medical, brings extensive experience in the development of navigation and robotic systems for spinal surgery. His expertise, which he also brought to Mako Surgical Corp in the development of robotic platforms, will be instrumental in achieving restor3d’s new goals. Kirstin Widding, with her background in strategic business development and product management, complements the leadership team with her extensive experience in the commercialization and implementation of orthopedic technologies.

With this strategic expansion, restor3d consolidates its position as an innovative player in the field of personalized medicine. The combination of 3D-printed implants with advanced surgical technologies underlines the company’s ambition to sustainably shape the future of orthopaedics and improve treatment outcomes for patients worldwide.